Effect of Kinesiotape Versus Myofascial Release on Postnatal Low Back Pain

Cairo University (CU)

Status: Completed

Conditions: Low Back Pain

Treatments: Other: Kinesiotape; Other: Myofascial release

Study type: Interventional

Funder types: Other

Identifiers

NCT06640543

P.T.REC/012/004348

Details and patient eligibility

About

This study aims to determine the difference between the effect of kinesiotape and myofascial release in the treatment of postnatal low back pain.

Full description

Postpartum back pain may occur in up to 44% of women after childbirth. People who have chronic back pain may have a limited range of motion and/or tenderness upon touch.

Therapeutic KT can benefit a wide variety of musculoskeletal and sports injuries, plus inflammatory conditions. According to the Kinesiotape Method Manual, this traction promotes an elevation of the epidermis and reduces pressure on the mechanoreceptors located below the dermis, thereby reducing nociceptive stimuli and low back pain.

Myofascial release (MFR) is a treatment that uses gentle pressure and stretching to facilitate the release of fascial restrictions caused by accidents, injury, stress, repetitive use, and traumatic or surgical scarring.

Myofascial release is a form of soft tissue therapy used to treat somatic dysfunction and accompanying pain and restriction of motion. This is accomplished by relaxing the contracted muscle, increasing circulation, increasing venous and lymphatic drainage, and stimulating the stretch reflex of muscles and overlying fascia so, reducing low back pain.

Enrollment: 60 patients

Sex: Female

Ages: 20 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Their ages will be ranged from 20 to 35 years old.
• Their body mass index (BMI) will not exceed 30 kg/m2.
• Women will be postnatal period by 6-8 weeks.
• All women will be diagnosed by the physician as postnatal low back pain.

Exclusion criteria

• Spinal fracture or any other neurological disorders.
• Lumbar disc herniation or degenerative disc disease
• Lumbar spinal stenosis from lumbar disc herniation, degenerative joint disease, or spondylolisthesis
• Women with BMI exceed 30 kg/m2.
• Patients who have polyneuropathy or other neurological disorders.
• Skin disease interferes with kinesiotape or myofascial release application.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

kinesiotape group

Experimental group

Description:

The participants will be treated with kinesiotape for 4 weeks

Treatment:

Other: Kinesiotape

myofascial release group

Experimental group

Description:

The participants will be treated with myofascial release for 4 weeks

Treatment:

Other: Myofascial release